Furthermore, analysis of HCC patient data from TCGA revealed that VIM-AS1 expression decreased, whereas EPHA3 mRNA expression increased with disease progression (Fig. 3e). The gene discussed is EPHA3; the disease is hepatocellular carcinoma.